What Is Aorta Atherosclerosis and How Is It Treated?

Aorta atherosclerosis is the buildup of fatty deposits, fibrous tissue, and calcium inside the wall of the aorta, the largest artery in the body. Over time, these deposits form plaques that stiffen and narrow the vessel, restrict blood flow, and can shed debris into smaller arteries downstream. Treatment depends on how advanced the disease is, ranging from cholesterol-lowering medications and lifestyle changes for most people to stenting or surgery when blockages become severe enough to threaten blood flow to the legs or organs.

How Plaques Form in the Aorta

Atherosclerosis begins when the inner lining of an artery gets irritated or damaged. Once that lining is activated, a chain reaction follows: cholesterol-carrying particles seep into the artery wall, immune cells rush in to clean them up, and the resulting mix of fat, cellular debris, and scar tissue slowly hardens into plaque.¹ In the aorta specifically, this process can unfold over decades without causing obvious symptoms, because the vessel is so wide that even a substantial plaque may not restrict flow the way a similar deposit would in a smaller coronary artery. That width is deceptive, though. Aortic plaques still matter because they can become unstable, rupture, and send fragments into the circulation, or they can signal widespread disease elsewhere in the body.

Why Certain Spots in the Aorta Are More Vulnerable

Not every inch of the aorta is equally prone to plaque. The curves, branches, and bends of the vessel create complex blood-flow patterns, and researchers have spent considerable effort mapping how those patterns relate to plaque location. In the aortic arch, where the vessel makes a sharp U-turn to send blood downward through the torso, the forces that blood exerts on the wall vary dramatically from one side of the curve to the other. Studies using computational fluid dynamics show that patients whose aortic arch plaques have ruptured tend to have higher peak wall shear stress at those sites than patients whose plaques remain intact.²

MRI-based flow measurements paint a complementary picture. When researchers correlated low wall shear stress with plaque location plane by plane along the aorta, they found a strong relationship in most segments, but the ascending aorta was an outlier: it showed flow patterns that should favor plaque yet rarely had any. And in areas where plaque had already formed, the zones of abnormal flow often shifted to adjacent wall segments rather than sitting right on top of the plaque itself.³ The practical takeaway is that the aortic arch, the descending aorta, and the area just above the point where the aorta splits into the iliac arteries are the usual trouble spots. The ascending aorta tends to be relatively spared, though it is not immune.

Who Is at Risk

The risk factors for aortic atherosclerosis overlap heavily with the usual suspects for heart disease: age, smoking, high blood pressure, diabetes, and elevated cholesterol. A large population-based study using transesophageal echocardiography identified age, male sex, prior coronary artery disease, wider pulse pressure, and diabetes as the strongest predictors of cardiovascular events among people with aortic plaque.⁴ Atrial fibrillation and a history of prior heart attack also raised the odds of stroke-related events in that same cohort.

One interesting wrinkle concerns sex differences. As the aorta ages, it widens and becomes more tortuous in everyone, but the changes are more pronounced in women. After age 40, women show greater increases in aortic tortuosity than men, and by the 60-to-69 and over-80 age brackets, women have significantly larger body-size-adjusted ascending aorta diameters.⁵ These structural changes affect blood-flow dynamics and may partly explain why the disease behaves differently in women as they get older.

Complications That Can Arise

Aortic atherosclerosis can cause trouble in several distinct ways, and not all of them involve the aorta itself narrowing enough to block blood flow.

• Embolism: When a plaque ruptures or erodes, cholesterol crystals and clot fragments can break loose and travel downstream. If they lodge in the small arteries of the feet, the result is what clinicians call blue toe syndrome, a painful discoloration caused by blocked blood supply to the toes.⁶ The debris typically originates from ulcerated plaques in the aorta or the iliac and femoral arteries below it, and the clinical picture can range from a single blue toe to widespread organ damage that mimics other systemic diseases.⁷
• Marker of generalized disease: Large plaques in the aortic arch are tied to a higher risk of combined cardiovascular events, but their link to stroke specifically weakens after adjusting for other risk factors. A long-term community study found that aortic arch plaques in stroke-free older adults predicted cardiovascular events overall but not ischemic stroke alone, suggesting the plaques serve more as a flag for severe atherosclerosis throughout the body than as a direct source of brain-bound clots.⁸
• Aneurysm formation: Atherosclerosis and abdominal aortic aneurysm frequently coexist. Whether the plaque directly weakens the aortic wall or the two conditions simply share the same risk factors has been debated for years. Evidence points in both directions: advanced plaques and the blood clots that form over them appear to contribute to the destruction of the smooth muscle and elastic tissue in the aortic wall, which is the structural failure that allows aneurysms to develop.⁹

How Aortic Atherosclerosis Is Detected

Most people with aortic atherosclerosis have no idea until it shows up incidentally on imaging done for another reason, or until a complication forces the issue. CT scans, MRI, and ultrasound can all reveal plaque, but the gold standard for detailed assessment of the thoracic aorta is transesophageal echocardiography (TEE), in which an ultrasound probe is passed into the esophagus to get a close-up view of the aorta from behind the heart.

In one study of over 2,000 patients who underwent TEE, about 42% had more than mild plaque somewhere in the thoracic aorta. The descending aorta and aortic arch were the most common locations. After adjusting for age, sex, high blood pressure, cholesterol, smoking, and diabetes, plaque in any thoracic aortic segment independently predicted death from all causes. Plaque in the descending aorta carried the strongest association, roughly doubling the risk compared to patients without plaque there.¹⁰

Calcium scoring via CT is another common approach, especially for the abdominal aorta, where calcium deposits are easy to spot. Among people who have zero coronary artery calcium, finding calcium in the thoracic aorta is linked to cardiovascular events and death in unadjusted analyses. However, after accounting for traditional risk factors like blood pressure and cholesterol, thoracic aortic calcium does not independently improve the prediction of who will have a heart attack or stroke.¹¹ In other words, the calcium is a sign of disease, but it tells you roughly the same story that your other risk factors already do.

Medical Treatment

For the majority of people, aortic atherosclerosis is managed with the same medical toolkit used for atherosclerosis anywhere else in the body: statins, blood-pressure control, blood-sugar management, and antiplatelet or anticoagulant therapy when warranted.

Statins occupy a central role. Research using MRI to track aortic plaque over time has shown that high-dose statin therapy produces meaningful shrinkage of plaque. In one study comparing high-dose to low-dose statin treatment, the high-dose group showed significantly greater reductions in aortic wall thickness and plaque volume, along with increases in the open lumen area.¹² A separate trial titrating rosuvastatin to reach lower LDL targets confirmed that more aggressive cholesterol lowering leads to greater thoracic aortic plaque regression, an effect that correlated with reductions in a blood marker of inflammation.¹³ These findings reinforce that aortic plaque is not a fixed feature of aging; it can be pushed back with aggressive enough lipid control.

For patients who have had a stroke and have aortic arch plaques, clinicians have debated whether to use blood thinners like warfarin or antiplatelet combinations. A trial comparing clopidogrel plus aspirin against warfarin in stroke patients with aortic arch plaques found no statistically significant difference in the rate of recurrent stroke and other vascular events between the two groups. Warfarin, however, was associated with more vascular deaths, while the antiplatelet combination had zero vascular deaths over a median follow-up of about three and a half years.¹⁴ The evidence leans toward antiplatelet therapy over warfarin for most of these patients, though treatment decisions are always individualized.

Stenting and Surgery

When atherosclerosis in the lower (infrarenal) aorta becomes severe enough to restrict blood flow to the legs, causing pain with walking or more advanced limb-threatening ischemia, mechanical intervention enters the picture. Stenting has emerged as a first-line option for infrarenal aortic blockages, particularly for stenoses rather than complete occlusions. Studies consistently report high technical success rates and excellent long-term patency. One long-term analysis found the vessels stayed open in all treated patients over five years, results at least as good as traditional surgical bypass.¹⁵

For the full range of infrarenal aortic disease, from a single narrowing to a total blockage extending into the iliac arteries, stenting has shown itself to be feasible and safe. For isolated stenoses, it is recommended as the first treatment option. For total occlusions, it is considered a reasonable alternative to open surgery rather than a clear-cut replacement.¹⁶ The appeal is obvious: stenting is less invasive, requires shorter hospital stays, and avoids the risks of open abdominal surgery. When results from smaller dedicated studies are consistent, reporting technical success in every patient treated and no major complications during follow-up, the confidence in this approach grows.¹⁷

In the thoracic aorta, the picture is different. Stenting is not a routine treatment for atherosclerotic plaques there, because the plaques themselves rarely cause flow-limiting stenosis in such a large vessel. Surgical intervention in the thoracic aorta tends to come up only when another procedure is needed, like aortic valve replacement, and the surgeon encounters a heavily calcified ascending aorta that makes the operation technically dangerous. In those cases, aortic endarterectomy, essentially scraping the calcified plaque out of the wall, can be used to create a safe site for clamping and suturing.¹⁸

Lifestyle Changes That Slow Progression

Quitting smoking is one of the most impactful things a person can do. In people with high blood pressure, smoking accelerates stiffening of the aorta and increases wave reflections that raise the workload on the heart. After quitting, arterial stiffness gradually improves, and after about a decade of abstinence, the difference between former smokers and people who never smoked becomes statistically insignificant.¹⁹ That is a long road, but it is a road that leads somewhere measurably better.

Diet also plays a role beyond just lowering cholesterol numbers. A randomized trial comparing a Mediterranean diet to a standard low-fat diet in people with established coronary heart disease tracked changes in carotid artery thickness over seven years. The Mediterranean diet group saw a small but significant decrease in artery wall thickness, while the low-fat diet group saw no change at all.²⁰ The study measured carotid rather than aortic arteries, but atherosclerosis is a systemic process, and dietary patterns that slow it in one vascular bed generally benefit others.

Experimental Approaches on the Horizon

Standard treatments focus on lowering cholesterol and managing risk factors. The next generation of therapies is aimed more directly at inflammation and the molecular events inside the plaque itself. Researchers have noted that anti-inflammatory drugs targeting specific immune pathways, including inhibitors of IL-6 and IL-1β as well as colchicine, could be evaluated for their effects on the inflammatory activity of aortic plaques that have spontaneously ruptured.²¹ Some of these drugs have already shown benefits in coronary artery disease trials, and extending them specifically to aortic disease is an active area of interest.

On a more futuristic track, nanotechnology-based drug delivery is being tested in animal models. One approach uses micelles, tiny spherical carriers, made from a material that reacts to the oxidative stress found at atherosclerotic plaque sites. These carriers simultaneously release an anti-inflammatory drug and scavenge the damaging reactive oxygen species that drive plaque instability. In laboratory and animal experiments, this dual-action strategy showed strong effects in reducing both inflammation and oxidative damage at aortic plaques.²² Whether this translates to humans remains to be seen, but the concept of delivering therapy directly to a plaque rather than flooding the entire body with a drug is an appealing direction.

Atherosclerosis in Ancient Humans

There is a common assumption that atherosclerosis is a disease of modern life, a product of fast food, sedentary habits, and tobacco. CT scans of ancient Egyptian mummies challenge that narrative. Out of 44 mummies with identifiable cardiovascular structures, about 45% showed definite or probable atherosclerosis, including calcification in the aorta, coronary arteries, carotid arteries, and leg arteries. The affected mummies spanned over 2,000 years of ancient Egyptian history.²³

These were people of high social status who did not smoke, did not eat processed food, and were probably more physically active than today’s average adult. They did, however, eat meat, lived in an agricultural society with access to carbohydrate-rich grains, and may have been exposed to chronic infections that drove systemic inflammation. The researchers concluded that the findings challenge any neat story in which atherosclerosis is purely a consequence of modern excess.²⁴ Aging, genetics, and inflammation appear to have been enough to produce the disease thousands of years before anyone had heard of cholesterol. Modern risk factors clearly accelerate it, but they did not invent it.